|
|
|
Insider
Information: |
Martin John C |
Relationship: |
Director |
City: |
Foster City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
2,895,138 |
|
Indirect Shares
|
2,684,281 |
|
|
Direct
Value |
$186,589,533 |
|
|
Indirect Value
|
$47,040,306 |
|
|
Total
Shares |
5,579,419 |
|
|
Total
Value |
$233,629,839 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Gilead Sciences Inc |
GILD |
Director |
2019-02-06 |
2,887,225 |
2016-08-05 |
731,917 |
Premium* |
|
Sarepta Therapeutics Inc |
SRPT |
Director |
2021-03-03 |
7,913 |
2020-02-28 |
0 |
Premium* |
|
Kronos Bio, Inc. |
KRON |
Director |
2020-10-14 |
0 |
2020-10-14 |
1,952,364 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
367 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 7 of 15
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-06-02 |
4 |
AS |
$81.32 |
$11,435,836 |
D/D |
(140,625) |
4,429,387 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-06-02 |
4 |
OE |
$8.01 |
$1,125,703 |
D/D |
140,625 |
4,570,012 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-07-01 |
4 |
AS |
$83.96 |
$11,929,961 |
D/D |
(140,625) |
4,429,387 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-07-01 |
4 |
OE |
$8.01 |
$1,125,703 |
D/D |
140,625 |
4,570,012 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-08-01 |
4 |
OE |
$8.01 |
$1,125,703 |
D/D |
140,625 |
4,570,012 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-08-01 |
4 |
AS |
$91.30 |
$12,871,813 |
D/D |
(140,625) |
4,429,387 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-09-02 |
4 |
AS |
$108.30 |
$15,277,914 |
D/D |
(140,625) |
4,429,387 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-09-02 |
4 |
OE |
$8.01 |
$1,125,703 |
D/D |
140,625 |
4,570,012 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-10-01 |
4 |
OE |
$8.01 |
$1,125,703 |
D/D |
140,625 |
4,570,012 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-10-01 |
4 |
AS |
$105.70 |
$14,893,845 |
D/D |
(140,625) |
4,429,387 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-11-03 |
4 |
OE |
$8.01 |
$1,125,703 |
D/D |
140,625 |
4,570,012 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-11-03 |
4 |
AS |
$109.78 |
$15,525,102 |
D/D |
(140,625) |
4,429,387 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-11-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
306,400 |
4,122,987 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-12-01 |
4 |
OE |
$8.01 |
$1,125,767 |
D/D |
140,633 |
4,263,620 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-12-01 |
4 |
AS |
$100.48 |
$14,164,829 |
D/D |
(140,633) |
4,122,987 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2015-01-02 |
4 |
OE |
$14.50 |
$2,175,375 |
D/D |
150,000 |
4,272,987 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2015-01-02 |
4 |
AS |
$95.01 |
$14,257,722 |
D/D |
(149,900) |
4,123,087 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2015-01-05 |
4 |
AS |
$96.65 |
$9,665 |
D/D |
(100) |
4,122,987 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2015-02-02 |
4 |
AS |
$105.13 |
$15,815,249 |
D/D |
(150,000) |
4,122,987 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2015-02-02 |
4 |
OE |
$14.50 |
$2,175,375 |
D/D |
150,000 |
4,272,987 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2015-02-13 |
4 |
A |
$85.61 |
$21,232 |
D/D |
248 |
4,123,235 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2015-02-17 |
4 |
D |
$103.84 |
$25,358,247 |
D/D |
(244,205) |
4,255,876 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2015-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
376,846 |
4,500,081 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2015-03-02 |
4 |
AS |
$103.51 |
$15,526,245 |
D/D |
(150,000) |
4,255,876 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2015-03-02 |
4 |
OE |
$14.50 |
$2,175,375 |
D/D |
150,000 |
4,405,876 |
0 |
- |
|
367 Records found
|
|
Page 7 of 15 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|